Emergent Biosolutions
EBS
EBS
184 hedge funds and large institutions have $1.02B invested in Emergent Biosolutions in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 63 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 172 → 184 (+12)
1.06% more ownership
Funds ownership: 80.77% → 81.84% (+1.1%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
184
Holding in Top 10
1
Calls
$594K
Puts
$330K
Top Buyers
| 1 | +$12.8M | |
| 2 | +$7.46M | |
| 3 | +$4.66M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$4.26M |
| 5 |
Goldman Sachs
New York
|
+$4.1M |
Top Sellers
| 1 | -$9.51M | |
| 2 | -$6.05M | |
| 3 | -$5.28M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$5.11M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$4.58M |